Report #2838880

Received Apr 30, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: —
Recovered: Unknown
Vaccinated: May 10, 2017
Onset: Sep 24, 2018
Days to onset: 502
Hospital days: —

Vaccines (3)

Type	Name	Manufacturer	Dose	Lot	Route / Site
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	1	M040412	—
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	2	N001533	—
HPV9	HPV (GARDASIL 9)	MERCK & CO. INC.	3	N021732	—

Symptoms (1)

Inappropriate schedule of product administration

Symptom narrative

first dose on 5/10/17, second dose on 6/21/17 and third dose on 9/24/18; This spontaneous report has been received from a consumer, regarding herself, a female patient of unknown age. The patient's pertinent medical history, concurrent conditions, drug allergies or concomitant medications were not reported. On 10-May-2017, the patient was vaccinated with Human Papillomavirus 9-valent Vaccine, Recombinant (lot #M040412, expiration date: 30-Jun-2019), dose number 1, on 21-Jun-2017, the dose number 2, and on 24-Sep-2018, dose number 3 (inappropriate schedule of product administration); all at a dose of 0.5 mL for prophylaxis.